Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Rotz

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.
Transplantation and Cellular Therapy|November 28, 2022
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant DiseasesLarisa Broglie, Brian D Friend, Saurabh Chhabra, et al.
JAMA Network Open|January 9, 2020
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell TransplantChristopher E Dandoy, Soyoung Kim, Min Chen, et al.
Transplantation and Cellular Therapy|July 25, 2022
Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell TransplantationSeth J Rotz, Jean C Yi, Betty K Hamilton, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Transplantation and Cellular Therapy|February 11, 2024
Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell TransplantationSeth J Rotz, Betty K Hamilton, Wei Wei, et al.
Transplantation and Cellular Therapy|February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Bone Marrow Transplantation|February 27, 2024
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 updateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Transplantation and Cellular Therapy|March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.
Transplantation and Cellular Therapy|November 28, 2022
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant DiseasesLarisa Broglie, Brian D Friend, Saurabh Chhabra, et al.
JAMA Network Open|January 9, 2020
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell TransplantChristopher E Dandoy, Soyoung Kim, Min Chen, et al.
Transplantation and Cellular Therapy|July 25, 2022
Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell TransplantationSeth J Rotz, Jean C Yi, Betty K Hamilton, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Transplantation and Cellular Therapy|February 11, 2024
Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell TransplantationSeth J Rotz, Betty K Hamilton, Wei Wei, et al.
Transplantation and Cellular Therapy|February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Bone Marrow Transplantation|February 27, 2024
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 updateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Transplantation and Cellular Therapy|March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Pageof 6